Inventor
RUAN ZHEMING
US13 patents
⚠️ This page may combine multiple inventors who share the name “RUAN ZHEMING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
12 patentsUS7579360B2Aug 25, 2009
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
BRISTOL MYERS SQUIBB CO37 citations92
US7459460B2Dec 2, 2008
Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
BRISTOL MYERS SQUIBB CO16 citations83
US10023576B2Jul 17, 2018
Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US11660311B2May 30, 2023
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO2 citations71
US10947263B2Mar 16, 2021
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO2 citations71
US11339185B2May 24, 2022
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations60
US12331045B2Jun 17, 2025
Substituted phenyl oxazolone compounds
BRISTOL MYERS SQUIBB CO0 citations58
US12473290B2Nov 18, 2025
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO0 citations51
US11945834B2Apr 2, 2024
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations51
US10519187B2Dec 31, 2019
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations50
US10214537B2Feb 26, 2019
Bicyclic heteroaryl amine compounds
BRISTOL MYERS SQUIBB CO0 citations41
US10744150B2Aug 18, 2020
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations40